BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 35750461)

  • 21. Resistance Exercise Training Increases Muscle Mass and Strength in Prostate Cancer Patients on Androgen Deprivation Therapy.
    Houben LHP; Overkamp M; VAN Kraaij P; Trommelen J; VAN Roermund JGH; DE Vries P; DE Laet K; VAN DER Meer S; Mikkelsen UR; Verdijk LB; VAN Loon LJC; Beijer S; Beelen M
    Med Sci Sports Exerc; 2023 Apr; 55(4):614-624. PubMed ID: 36534950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does androgen deprivation impact associations between cognition and strength, fitness and function in community-dwelling men with prostate cancer? A cross-sectional study.
    Mundell NL; Owen PJ; Dalla Via J; Macpherson H; Daly RM; Fraser SF
    BMJ Open; 2021 Dec; 11(12):e058478. PubMed ID: 36415046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fitness outcomes from a randomised controlled trial of exercise training for men with prostate cancer: the ENGAGE study.
    Gaskin CJ; Fraser SF; Owen PJ; Craike M; Orellana L; Livingston PM
    J Cancer Surviv; 2016 Dec; 10(6):972-980. PubMed ID: 27098346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protocol for GET FIT Prostate: a randomized, controlled trial of group exercise training for fall prevention and functional improvements during and after treatment for prostate cancer.
    Winters-Stone KM; Li F; Horak F; Dieckmann N; Hung A; Amling C; Beer TM
    Trials; 2021 Nov; 22(1):775. PubMed ID: 34742325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Weight loss for overweight and obese patients with prostate cancer: a study protocol of a randomised trial comparing clinic-based versus Telehealth delivered EXercise and nutrition intervention (the TelEX trial).
    Galvão DA; Taaffe DR; Hayne D; Lopez P; Lyons-Wall P; Tang CI; Chambers SK; Devine A; Spry N; Jeffery E; Kudiarasu C; Joseph D; Newton RU
    BMJ Open; 2022 Jun; 12(6):e058899. PubMed ID: 35667725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lifestyle changes for improving disease-specific quality of life in sedentary men on long-term androgen-deprivation therapy for advanced prostate cancer: a randomised controlled trial.
    Bourke L; Gilbert S; Hooper R; Steed LA; Joshi M; Catto JW; Saxton JM; Rosario DJ
    Eur Urol; 2014 May; 65(5):865-72. PubMed ID: 24119318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR.
    Galvão DA; Spry N; Denham J; Taaffe DR; Cormie P; Joseph D; Lamb DS; Chambers SK; Newton RU
    Eur Urol; 2014 May; 65(5):856-64. PubMed ID: 24113319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium and vitamin D supplementation during androgen deprivation therapy for prostate cancer: a critical review.
    Datta M; Schwartz GG
    Oncologist; 2012; 17(9):1171-9. PubMed ID: 22836449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of progressive resistance training combined with a whey-protein drink and vitamin D supplementation on glycaemic control, body composition and cardiometabolic risk factors in older adults with type 2 diabetes: study protocol for a randomized controlled trial.
    Daly RM; Miller EG; Dunstan DW; Kerr DA; Solah V; Menzies D; Nowson CA
    Trials; 2014 Nov; 15():431. PubMed ID: 25376884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomised controlled trial to evaluate the efficacy of a 6 month dietary and physical activity intervention for prostate cancer patients receiving androgen deprivation therapy.
    Haseen F; Murray LJ; O'Neill RF; O'Sullivan JM; Cantwell MM
    Trials; 2010 Aug; 11():86. PubMed ID: 20704726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Different Exercise Modalities on Fatigue in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: A Year-long Randomised Controlled Trial.
    Taaffe DR; Newton RU; Spry N; Joseph D; Chambers SK; Gardiner RA; Wall BA; Cormie P; Bolam KA; Galvão DA
    Eur Urol; 2017 Aug; 72(2):293-299. PubMed ID: 28249801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive decline in prostate cancer patients undergoing ADT: a potential role for exercise training.
    Mundell NL; Daly RM; Macpherson H; Fraser SF
    Endocr Relat Cancer; 2017 Apr; 24(4):R145-R155. PubMed ID: 28209634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attenuation of Resting but Not Load-Mediated Protein Synthesis in Prostate Cancer Patients on Androgen Deprivation.
    Hanson ED; Nelson AR; West DW; Violet JA; O'Keefe L; Phillips SM; Hayes A
    J Clin Endocrinol Metab; 2017 Mar; 102(3):1076-1083. PubMed ID: 28359098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SYNERGIC TRIAL (SYNchronizing Exercises, Remedies in Gait and Cognition) a multi-Centre randomized controlled double blind trial to improve gait and cognition in mild cognitive impairment.
    Montero-Odasso M; Almeida QJ; Burhan AM; Camicioli R; Doyon J; Fraser S; Li K; Liu-Ambrose T; Middleton L; Muir-Hunter S; McIlroy W; Morais JA; Pieruccini-Faria F; Shoemaker K; Speechley M; Vasudev A; Zou GY; Berryman N; Lussier M; Vanderhaeghe L; Bherer L
    BMC Geriatr; 2018 Apr; 18(1):93. PubMed ID: 29661156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial.
    Cormie P; Galvão DA; Spry N; Joseph D; Chee R; Taaffe DR; Chambers SK; Newton RU
    BJU Int; 2015 Feb; 115(2):256-66. PubMed ID: 24467669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of recreational soccer in men with prostate cancer undergoing androgen deprivation therapy: study protocol for the 'FC Prostate' randomized controlled trial.
    Uth J; Schmidt JF; Christensen JF; Hornstrup T; Andersen LJ; Hansen PR; Christensen KB; Andersen LL; Helge EW; Brasso K; Rørth M; Krustrup P; Midtgaard J
    BMC Cancer; 2013 Dec; 13():595. PubMed ID: 24330570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health-related quality of life for immediate versus delayed androgen-deprivation therapy in patients with asymptomatic, non-curable prostate cancer (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial.
    Duchesne GM; Woo HH; King M; Bowe SJ; Stockler MR; Ames A; D'Este C; Frydenberg M; Loblaw A; Malone S; Millar J; Tai KH; Turner S
    Lancet Oncol; 2017 Sep; 18(9):1192-1201. PubMed ID: 28760403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Promoting calcium and vitamin D intake to reduce the risk of osteoporosis in men on androgen deprivation therapy for recurrent prostate cancer.
    Davison BJ; Wiens K; Cushing M
    Support Care Cancer; 2012 Oct; 20(10):2287-94. PubMed ID: 22138848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does exercise impact gut microbiota composition in men receiving androgen deprivation therapy for prostate cancer? A single-blinded, two-armed, randomised controlled trial.
    Newton RU; Christophersen CT; Fairman CM; Hart NH; Taaffe DR; Broadhurst D; Devine A; Chee R; Tang CI; Spry N; Galvão DA
    BMJ Open; 2019 Apr; 9(4):e024872. PubMed ID: 30987986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of a multicomponent exercise program combined with calcium-vitamin D
    Matthews J; Torres SJ; Milte CM; Hopkins I; Kukuljan S; Nowson CA; Daly RM
    Eur J Nutr; 2020 Apr; 59(3):1081-1091. PubMed ID: 30993400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.